Altrinsic Global Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Altrinsic Global Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-158,154	Closed	-$5.18M	–	92
2014 Q3	$5.18M	Sell	158,154 -10,000	-6%	-$352K	0.1%	59
2014 Q2	$6.45M	Hold	168,154	–	–	0.11%	62
2014 Q1	$6.69M	Buy	168,154 +55,000	+49%	+$2.46M	0.11%	61
2013 Q4	$4.23M	Hold	113,154	–	–	0.07%	63
2013 Q3	$5.16M	Hold	113,154	–	–	0.09%	57
2013 Q2	$3.06M	Buy	+113,154	New	+$2.59M	0.05%	59

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Altrinsic Global Advisors's KYTH Position: Q4 2014 in Review

Altrinsic Global Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 158,154 shares — an estimated $5.18M sold.

Altrinsic Global Advisors first reported a position in KYTH in Q2 2013 and held it in 6 quarters. The position peaked at $6.69M in Q1 2014. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

Altrinsic Global Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
Altrinsic Global Advisors sold 158,154 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $5.18M.
Altrinsic Global Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 6 quarters.
Altrinsic Global Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.69M in Q1 2014.
106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on Altrinsic Global Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.